Serial #87390143
DEAD

Serial Number

87390143

Owner

BioNTech US Inc.

Attorney

Monica Riva Talley

Filing Date

Mar 29, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #87390143 Trademark

Serial Number: 87390143 • Registration: 5788300

Serial #87390143 is a trademark filed by BioNTech US Inc. on March 29, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BioNTech US Inc. (12 trademarks)

Cambridge, MA 02139

Entity Type: 03

Neon Therapeutics, Inc. (15 trademarks)

40 Erie Street, Suite 110
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

March 29, 2017

Registration Date

June 25, 2019

Published for Opposition

February 20, 2018

Cancellation Date

January 9, 2026

Goods & Services

Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations

Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 9, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 25, 2024 REM1
NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Jun 3, 2022 C.7C
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 2, 2022 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jan 6, 2022 ES7R
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 21, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 18, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 24, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 24, 2019 AITU
USE AMENDMENT FILED
Apr 11, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 11, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 18, 2018 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2018 TCCA
SOU EXTENSION 1 GRANTED
Oct 16, 2018 EX1G
SOU EXTENSION 1 FILED
Oct 16, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 16, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 17, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Feb 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 31, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 10, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 10, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 10, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 10, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2017 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2017 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 28, 2017 GPRN
PRIORITY ACTION E-MAILED
Jun 28, 2017 GPRA
PRIORITY ACTION WRITTEN
Jun 28, 2017 CPRA
ASSIGNED TO EXAMINER
Jun 21, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 5, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2017 NWOS
NEW APPLICATION ENTERED
Apr 1, 2017 NWAP